Publication | Closed Access

Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive–compulsive disorder

PsychiatryAddictionPsychopharmacologyPsychologyNeuropsychiatryNeuropharmacologySocial SciencesCompulsive BehaviorNeuroscienceBiological PsychiatryTransgenic ModelMedicineGlutamatergic DrugsPsychopathologySymptomatic BehaviorTic Disorder